Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmaceutical Research

• Publication date

  2015-07-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11095-015-1747-6PMID 26138669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique.

  2013cited by this paper
• An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.

  2012cited by this paper
• Effects of RNA interference-induced Smad3 gene silencing on pulmonary fibrosis caused by paraquat in mice

  2012cited by this paper
• Pseudotyped Adeno-Associated Virus 2/9-Delivered CCL11 shRNA Alleviates Lung Inflammation in an Allergen-Sensitized Mouse Model

  2012cited by this paper
• Chitosan-interferon-β gene complex powder for inhalation treatment of lung metastasis in mice.

  2011cited by this paper
• Pulmonary delivery of therapeutic siRNA

  2011cited by this paper
• Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice.

  2011cited by this paper
• Attenuation of fibrosis in vitro and in vivo with SPARC siRNA

  2010cited by this paper
• Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.

  2010cited by this paper
• Chitosan-based formulations for delivery of DNA and siRNA.

  2010cited by this paper
• Chitosan as a carrier for targeted delivery of small interfering RNA.

  2010cited by this paper
• Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.

  2009cited by this paper
• Lipidic Systems for In Vivo siRNA Delivery

  2009cited by this paper
• The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.

  2009cited by this paper
• Dual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescence.

  2009cited by this paper
• Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation.

  2008cited by this paper
• Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.

  2007cited by this paper
• RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.

  2006cited by this paper
• Inhibition of respiratory viruses by nasally administered siRNA

  2005cited by this paper
• The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer.

  2005cited by this paper
• Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis.

  2005cited by this paper
• Stabilization of Proteins in Dry Powder Formulations Using Supercritical Fluid Technology

  2004cited by this paper
• Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process.

  2003cited by this paper
• Improvement of insulin absorption from intratracheally administrated dry powder prepared by supercritical carbon dioxide process.

  2003cited by this paper
• Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes

  2000cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper

• Dry powder inhalation of siRNA therapeutics: Emerging strategies for pulmonary gene silencing.

  2025cites this paper
• Aerogels Part 1: A Focus on the Most Patented Ultralight, Highly Porous Inorganic Networks and the Plethora of Their Advanced Applications

  2025cites this paper
• Inhalable Dry Powders for Lung mRNA Delivery

  2024cites this paper
• Alternative routes for parenteral nucleic acid delivery and related hurdles: highlights in RNA delivery

  2024cites this paper
• Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery

  2024cites this paper
• Design Considerations for Intratracheal Delivery Devices to Achieve Proof-of-Concept Dry Powder Biopharmaceutical Delivery in Mice

  2023cites this paper
• Dextran Mass Ratio Controls Particle Drying Dynamics in a Thermally Stable Dry Powder Vaccine for Pulmonary Delivery

  2022cites this paper
• Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside

  2022cites this paper
• Dry Powder Pharmaceutical Biologics for Inhalation Therapy.

  2021cites this paper
• Chemie der Chitosan‐Aerogele: Lenkung der dreidimensionalen Poren für maßgeschneiderte Anwendungen

  2020cites this paper
• Inhaled RNA Therapy: From Promise to Reality

  2020cites this paper
• Chemistry of Chitosan Aerogels: Three-Dimensional Pore Control for Tailored Applications.

  2020cites this paper
• High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin.

  2019cites this paper
• The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

  2019cites this paper
• Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice

  2018cites this paper
• Current status and promising future of inhalable formulations.

  2017cites this paper
• Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside

  2016cites this paper